Medibeacon
Clinical trials sponsored by Medibeacon, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New eye dye could make retinal scans safer and sharper Results expected Dec 2026 (estimated)
- Glow-in-the-dark dye could save kidneys during surgery Results expected Dec 2026 (estimated)
- Sticker on chest could replace needles for kidney checks in heart failure Results expected Jan 2027 (estimated)
- Can a steak dinner reveal how well your kidneys really work? Results expected Jan 2027 (estimated)
-
Sticker on chest could replace needles for kidney checks in heart failure
Diagnosis Recruiting nowThis study tests a new device that uses a sensor placed on the chest to measure kidney function in 15 adults with heart failure. Participants receive an injection of a fluorescent dye (Relmapirazin) and a standard contrast agent (iohexol), then the sensor tracks how quickly the d…
Sponsor: MediBeacon • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
New eye dye could make retinal scans safer and sharper
Diagnosis Recruiting nowThis study tests a new dye called MB-102 for taking pictures of the back of the eye (retina) to diagnose conditions like diabetic retinopathy and macular degeneration. About 10 adults with healthy or diseased eyes will receive both the new dye and a standard dye to compare safety…
Early phase 1 • Sponsor: MediBeacon • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC